Investigators also look to evaluate linvoseltamab in relapsed/refractory numerous myeloma as Element of the stage three LINKER-MM3 demo. Individuals with a prior record of CNS metastases could enroll on study provided there is no existing proof of active illness at enough time of enrollment testing, sample sizing was decided on https://janetf443rcm6.ktwiki.com/user